MedTrace Logo

Tranexamic Acid in Major Orthopedic Surgery: Comparison of 3 Dosage Regimen

NCT03573245 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2018-06-29

No results posted yet for this study

Summary

Tranexamic acid has been shown to be effective in reducing blood loss and transfusion in orthopedic surgery. It remains unknown the ideal therapeutic regimen. The goal of this study is to compare 3 dosage regimen of tranexamic acid in patients submitted to major orthopedic surgery.

Conditions

Interventions

DRUG

Tranexamic Acid

Tranexamic acid effect on perioperative bleeding in orthopedic surgery

Sponsors & Collaborators

  • CUF Santarém Hospital

    lead OTHER

Principal Investigators

  • Angela Sa, MD · CUF Santarem Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-04-01
Completion
2019-04-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03573245 on ClinicalTrials.gov